After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.
Daily News Roundup
After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.
A new study suggests a possible link between the use of oral contraceptives and rising prostate cancer rates.
A genetically engineered smallpox vaccine improved the survival of liver cancer patients participating in a phase II clinical trial.
Researchers have developed a way to activate cancer fighting drugs by pulsing them with light, which could make such therapies safer.
Researchers scan the molecules in spider venom for anti-cancer effects in tissue culture.
Researchers diagnose the second oldest known case of prostate cancer in a two-thousand-year-old-Egyptian mummy.
A group of microRNAs can inhibit the formation of induced pluripotent stem cells, and may provide a target for more efficient reprogramming of somatic cells.
Living conditions in early life can have lasting, widespread effects on DNA methylation.
The high court in Europe decided that researchers are barred from filing EU patents on work involving human embryonic stem cells.
The case challenging the right of a healthcare company to patent cancer genes may make it all the way to the US Supreme Court.